1,080
Views
3
CrossRef citations to date
0
Altmetric
Immune Thrombocytopenia

The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura

, , , &

References

  • Schwartz RS. Immune thrombocytopenic purpura from agony to agonist. N Engl J Med. 2007;357(22):2299–2301. doi: 10.1056/NEJMe0707126
  • Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–186. doi: 10.1182/blood-2009-06-225565
  • Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994;83:435–445.
  • Koulova L, Alexandrescu D, Dutcher JP, et al. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. Am J Hematol. 2005;78(1):49–54. doi: 10.1002/ajh.20243
  • Weng WK, Levy R. Two immunoglobulin G fragment C receptor polymorphisms independently predictresponse to rituximab in patients with follicular lymphoma. J Clin Oncol. 2003;21(21):3940–3947. doi: 10.1200/JCO.2003.05.013
  • Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Adv Immunol. 1994;57:1–127. doi: 10.1016/S0065-2776(08)60671-9
  • Radaev S, Sun P. Recognition of immunoglobulins by Fcγ receptors. Mol Immunol. 2002;38:1073–1083. doi: 10.1016/S0161-5890(02)00036-6
  • Van der Pol WL, Van de Winkel JGJ. Receptor polymorphisms: risk factors for disease. Immunogenetics. 1998;48:222–232. doi: 10.1007/s002510050426
  • van Sorge NM, van der Pol WL, van de Winkel JG. Fc gamma R polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens. 2003;61:189–202. doi: 10.1034/j.1399-0039.2003.00037.x
  • Mellor JD, Brown MP, Irving HR, et al. A critical review of the role of Fc gamma receptor polymorphisms in the response to monoclonal antibodies in cancer. J Hematol Oncol. 2013;6:1. doi: 10.1186/1756-8722-6-1
  • Wu J, Edberg JC, Redecha PB, et al. A novel polymorphism of Fc-gamma-RIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest. 1997;100:1059–1070. doi: 10.1172/JCI119616
  • Parren PW, Warmerdam PA, Boeije LC, et al. On the interaction of IgG subclasses with the low affinity Fc-gamma-RIIa (CD32) on human monocytes, neutrophils, and platelets: analysis of a functional polymorphism to human IgG2. J Clin Invest. 1992;90:1537–1546. doi: 10.1172/JCI116022
  • Warmerdam PA, van de Winkel JG, Vlug A, et al. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol. 1991;147(4):1338–1343.
  • Ghesquieres H, Cartron G, Seymour JF, et al. Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. Blood. 2012;120(13):2650–2657. doi: 10.1182/blood-2012-05-431825
  • Dornan D, Spleiss O, Yeh RF, et al. Effect of FCGR2A and FCGR3A variants on CLL outcome. Blood. 2010;116(20):4212–4222. doi: 10.1182/blood-2010-03-272765
  • Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–2393. doi: 10.1182/blood-2008-07-162503
  • Israelsson E, Vafa M, Maiga B, et al. Differences in Fcgamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali. Malar J. 2008;15:7–175.
  • Koene HR, Kleijer M, Algra J, et al. Fc gammaRIIIa-158 V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood. 1997;90(3):1109–1114.
  • Peñalver J, Vilches C, Jarque I, et al. Influence of the FCGR3A-158 V/F and FCGR2A-131 H/R polymorphism on the response to rituximab therapy in immune thrombocytopenic purpura and autoimmune hemolytic Anemia. Blood. 2007;110(11):2097.
  • Fujimoto TT, Inoue M, Shimomura T, et al. Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura. Br J Haematol. 2001;115:125–130. doi: 10.1046/j.1365-2141.2001.03109.x
  • Eyada TK, Farawela HM, Khorshied MM, et al. FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt. Blood Coagul Fibrinolysis. 2012;23(1):64–68. doi: 10.1097/MBC.0b013e32834ddf2f

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.